Hui Hao-Shen

Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms

Pontus Lundberg, Axel Karow, Ronny Nienhold et al. · Blood · 2014 · 641 citations

Medicine, Genetics, Hematology +17

Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice

Ralph Tiedt, Hui Hao-Shen, Marta Sobas et al. · Blood · 2007 · 434 citations · Full text

Veterinary Medicine, Genetics, Molecular Genetics +12

Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo

Ralph Tiedt, Tibor Schomber, Hui Hao-Shen et al. · Blood · 2006 · 418 citations

Life Sciences, Cell Biology, Genetics +14

Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms

Franz X. Schaub, Renate Looser, Sai Li et al. · Blood · 2010 · 175 citations · Full text

Veterinary Medicine, Genetics, Hematology +13

Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms

Simona Stivala, Tamara Codilupi, Šime Brkić et al. · Journal of Clinical Investigation · 2019 · 126 citations · Full text

Life Sciences, Oncology, Pharmacology +16